{
    "organizations": [],
    "uuid": "9cc61bfa5b169003d30fca2cb3b989fcb896a2c4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-trovagene-announces-activation-of/brief-trovagene-announces-activation-of-two-additional-clinical-trial-sites-to-conduct-early-stage-leukemia-study-idUSASB0C5EE",
    "ord_in_thread": 0,
    "title": "Trovagene Announces Activation Of Two Additional Clinical Trial Sites To Conduct Early Stage Leukemia Study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - Trovagene Inc:\n* TROVAGENE ANNOUNCES ACTIVATION OF TWO ADDITIONAL CLINICAL TRIAL SITES TO CONDUCT ITS PHASE 1B/2 STUDY OF PCM-075 IN PATIENTS WITH AML Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-13T21:23:00.000+02:00",
    "crawled": "2018-02-14T12:50:07.021+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "trovagene",
        "inc",
        "trovagene",
        "announces",
        "activation",
        "two",
        "additional",
        "clinical",
        "trial",
        "site",
        "conduct",
        "phase",
        "study",
        "patient",
        "aml",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}